SCHEMBL9834772

SCHEMBL9834772

NC(=O)C1C(=O)Nc2cc3[nH]c(O)nc3cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835280 0.87 KDM4E (0.30)
SCHEMBL9833068 0.81 TDP2 (0.44)
SCHEMBL9834375 0.80 PGR (0.36)
SCHEMBL9834093 0.77 MAOB (0.34)
SCHEMBL9834590 0.77 PGR (0.40)
SCHEMBL10565679 0.75 AMY1A (0.33)
SCHEMBL9834699 0.75 ADAMTS5 (0.38)
SCHEMBL9832544 0.74 CHRNB2 (0.42)
SCHEMBL9834194 0.72
SCHEMBL9834558 0.71 CHRNB2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed